...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

Rentschler Appoints New Chief Business Officer

| Print |
Thursday, 07 March 2013 15:00 (UTC + 1)

Rentschler logo new

Seasoned industry expert Frank Ternes joins executive Management Board

Laupheim, Germany, March 7, 2013 / B3C newswire / - Rentschler Biotechnologie GmbH, a leading contract manufacturing organization for the development and production of biopharmaceuticals, today announced the appointment of Frank Ternes to the position of Chief Business Officer effective February 1, 2013. In this position, Mr. Ternes will contribute to the success of the organization by leading the planning, development and execution of all business development, sales & marketing and project management activities.

"Mr. Ternes is an excellent addition to Rentschler's management board," says Dr. Nikolaus F. Rentschler, CEO and owner of Rentschler. "With his broad experience in the contract manufacturing business, he has a keen understanding of technology, a strong customer focus, and a proven track record for achieving success.”

Frank Ternes brings more than 25 years of experience from Operations and Technology at Boehringer Ingelheim where he last served as Senior Vice President of Biopharmaceutical Contract Manufacturing.

Mr. Ternes holds a degree equivalent to a master’s degree in economics from the University of Bonn, Germany.

Port Ternes
Caption: Frank Ternes, CBO, Rentschler Biotechnologie GmbH
(For high resolution picture please right click on the image and select "Save target as...")


About Rentschler

Rentschler Biotechnologie GmbH is a global full-service contract manufacturer with more than 35 years of experience in the development, production and approval of biopharmaceuticals in compliance with international GMP standards (EMA/FDA). Rentschler has nine GMP suites with volumes of 30, 50, 250, 500, 1,000 and 2,500 liters, allowing the production of material for clinical trials (phases I to III) and for market supply and also provides regulatory advice, protein analytics, quality control, and the sterile filling of syringes and injection vials. The company is family-owned and independent and has currently about 650 employees.


Contact

Friederike Braun
Director Marketing
Rentschler Biotechnologie GmbH
Phone: +49 7392 701-478
This e-mail address is being protected from spambots. You need JavaScript enabled to view it